Cefdinir
Community-acquired pneumonia, Acute exacerbations of chronic bronchitis, Acute maxillary sinusitis, Pharyngitis/tonsillitis, Uncomplicated skin and skin structure infections
Indications
- Community-acquired pneumonia
- Acute exacerbations of chronic bronchitis
- Acute maxillary sinusitis
- Pharyngitis/tonsillitis
- Uncomplicated skin and skin structure infections
Adult dosing
- pneumonia: dose: 300; unit: mg; route: PO; interval: q12h for 10 days; fixed: true; labelExcerpt: Community-Acquired Pneumonia 300 mg q12h 10 days
- bronchitis: dose: 300; unit: mg; route: PO; interval: q12h or 600 mg q24h for 5 to 10 days; fixed: true; labelExcerpt: Acute Exacerbations of Chronic Bronchitis 300 mg q12h or 600 mg q24h 5 to 10 days 10 days
- sinusitis: dose: 300; unit: mg; route: PO; interval: q12h or 600 mg q24h for 10 days; fixed: true; labelExcerpt: Acute Maxillary Sinusitis 300 mg q12h or 600 mg q24h 10 days 10 days
- pharyngitis: dose: 300; unit: mg; route: PO; interval: q12h or 600 mg q24h for 5 to 10 days; fixed: true; labelExcerpt: Pharyngitis/Tonsillitis 300 mg q12h or 600 mg q24h 5 to 10 days 10 days
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- failure: 300 mg once daily; hemodialysis: 300 mg or 7 mg/kg every other day; note: CrCl <30 mL/min requires dose adjustment to 300 mg daily. Label: "For adult patients with creatinine clearance <30 mL/min, the dose of cefdinir should be 300 mg given once daily."
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Known allergy to cephalosporin class
Clinical pearls
- May be taken without regard to meals.
- Monitor for Clostridium difficile associated diarrhea (CDAD).
- Cross-hypersensitivity may occur in patients allergic to penicillins.
Source and review
- DailyMed label (cefdinir), Set ID 3c2130f9-a0d8-4a4e-bcad-36379202b7bb, effective 2026-10-14. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties